The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

BACKGROUND: Our previous genome-wide association study using the MA.27 aromatase inhibitors adjuvant trial identified SNPs in the long noncoding RNA MIR2052HG associated with breast cancer-free interval. MIR2052HG maintained ERα both by promoting AKT/FOXO3-mediated ESR1 transcription and by limiting...

Descripción completa

Detalles Bibliográficos
Autores principales: Cairns, Junmei, Ingle, James N., Kalari, Krishna R., Shepherd, Lois E., Kubo, Michiaki, Goetz, Matthew P., Weinshilboum, Richard M., Wang, Liewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448248/
https://www.ncbi.nlm.nih.gov/pubmed/30944027
http://dx.doi.org/10.1186/s13058-019-1130-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448248/
https://www.ncbi.nlm.nih.gov/pubmed/30944027
http://dx.doi.org/10.1186/s13058-019-1130-3

Ejemplares similares